Leadership

Sharat Singh, PhD

Head of Research

Sharat Singh brings over 25 years of experience as a dynamic and innovative scientific leader to his role at Biora Therapeutics, where he is focused on development of the company’s ingestible drug-device combination product candidates.

Dr. Singh previously held scientific leadership roles at Aclara Biosciences, Prometheus Laboratories, and Nestle Health Sciences, where he established partnerships with leading biotech/pharmaceutical companies and conducted multiple phase I/II clinical trials in both oncology and gastrointestinal disease. As Chief Scientific Officer at Prometheus Laboratories, he worked on topical formulation of budesonide for both Crohn’s disease (marketed as Endocort) and ulcerative colitis.

Dr. Singh is the key inventor of multiple platform technologies (CEER, ANSER, eTag, and LOCI) and has authored over 100 patents. In his academic career, Sharat conducted inter-disciplinary research as a postdoctoral fellow at Columbia University. He holds a PhD in Chemistry from IISc, Bangalore, and has authored over 100 manuscripts and presentations.